{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:23:11Z","timestamp":1791937391596,"version":"4.3.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.dsx.2018.11.027","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T17:15:17Z","timestamp":1542215717000},"page":"626-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Relation between plasma Apelin level and peripheral neuropathy in Type 2 diabetic patients"],"prefix":"10.1016","volume":"13","author":[{"given":"Salwa Seddik","family":"Hosny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merhan Samy","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana Hashem","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainb","family":"YousryHelal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2018.11.027_bib1","article-title":"Diagnosis of diabetes mellitus","volume":"35","author":"ADA","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.11.027_bib2","first-page":"11","article-title":"Diabetic neuropathy","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.dsx.2018.11.027_bib3","series-title":"Diabetic neuropathy management, pharmacolther diabetic neuropathy","first-page":"120","author":"Edwards","year":"2008"},{"key":"10.1016\/j.dsx.2018.11.027_bib4","article-title":"Genetic variant in the apelin gene","author":"Sentinelli","year":"2016","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.dsx.2018.11.027_bib5","doi-asserted-by":"crossref","first-page":"E1161","DOI":"10.1152\/ajpendo.00598.2009","article-title":"Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans","volume":"298","author":"Dray","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.dsx.2018.11.027_bib6","first-page":"892","article-title":"Association of apelin, endoglin and endocan with diabetic peripheral neuropathy in type 2 diabetic patients","volume":"20","author":"Yilmaz","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"10.1016\/j.dsx.2018.11.027_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2018.11.027_bib8","first-page":"153","article-title":"An electrodiagnostic approach to the evaluation of peripheral neuropathies","author":"Mark","year":"2013","journal-title":"Phys Med RehabilClin N Am"},{"key":"10.1016\/j.dsx.2018.11.027_bib9","article-title":"Promoting effects of the adipokine, apelin, on diabetic nephropathy","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.dsx.2018.11.027_bib10","first-page":"241","article-title":"Plasma apelin levels in diabetic patients with and without neuropathy","volume":"4","author":"Mehmet","year":"2009","journal-title":"J\u00a0Med"},{"issue":"12","key":"10.1016\/j.dsx.2018.11.027_bib11","article-title":"Altered glucose homeostasis is associated with increased serum apelin levels in type 2 DM","volume":"7","author":"Maria","year":"2012","journal-title":"J.\u00a0PLoS"},{"key":"10.1016\/j.dsx.2018.11.027_bib12","first-page":"2547","article-title":"Evaluation of Apelin and insulin resistance","volume":"21","author":"Xianchang","year":"2015","journal-title":"Med SciMonit"},{"key":"10.1016\/j.dsx.2018.11.027_bib13","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1007\/s11695-009-9955-y","article-title":"Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus","volume":"19","author":"Soriguer","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/j.dsx.2018.11.027_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/2356-8062.205205","article-title":"The relationship between serum apelin level and different grades of diabetic nephropathy","volume":"3","author":"Alaa","year":"2017","journal-title":"Egyptian Journal of Obesity, Diabetes and Endocrinology"},{"key":"10.1016\/j.dsx.2018.11.027_bib15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-2006-948309","article-title":"Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects","volume":"114","author":"Li","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118304776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118304776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T23:48:59Z","timestamp":1547164139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118304776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1871402118304776"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.11.027","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relation between plasma Apelin level and peripheral neuropathy in Type 2 diabetic patients","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}